Related Experiment Videos

Myocardial bridging of the coronary arteries

K S Channer1, E Bukis, G Hartnell

  • 1Department of Cardiology, Bristol Royal Infirmary.

Clinical Radiology
|July 1, 1989
PubMed

Insights

Myocardial bridging, a condition where coronary arteries narrow during systole, was found in 1.4% of patients. This condition occurred more often than expected in normal angiograms and was linked to left ventricular hypertrophy and coronary artery disease.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Pathology

Background:

  • Myocardial bridging is a congenital anomaly where a segment of a coronary artery tunneled through the heart muscle.
  • Its prevalence and clinical significance, especially in relation to other cardiovascular conditions, require further elucidation.

Purpose of the Study:

  • To determine the prevalence of myocardial bridging in patients undergoing coronary angiography.
  • To investigate the association of myocardial bridging with left ventricular hypertrophy and coronary artery disease.

Main Methods:

  • Retrospective analysis of 1102 consecutive coronary angiograms.
  • Identification and characterization of myocardial bridging based on systolic narrowing.
  • Correlation of bridging with patient demographics, comorbidities, and angiographic findings.

Main Results:

  • Myocardial bridging was identified in 1.4% (16 out of 1102) of cases, predominantly affecting the left anterior descending artery.
  • Bridging was observed more frequently than anticipated in angiograms without significant coronary artery disease.
  • In patients with left ventricular hypertrophy, bridging involved longer segments and caused more severe compression.
  • No association with atheroma was found at the site of bridging in patients with coronary artery disease.

Conclusions:

  • Myocardial bridging is an underrecognized finding on coronary angiography.
  • The association with left ventricular hypertrophy suggests a potential role in cardiac dysfunction.
  • Further research is warranted to establish the pathogenic role of myocardial bridging in ischemic heart disease.

Related Concept Videos